HEALEY ALS Platform Trial Surpasses 50% Dosing Milestone Ahead of Schedule
129 of 240 participants dosed in Regimen I of the HEALEY ALS Platform Trial evaluating NUZ-001
Achievement follows recent expansion of Regimen I from 160 to ...



















